Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Accurate dermatological diagnosis naturally necessitates equitable performance across diverse populations, yet a systematic lack of expertly annotated images, especially for underrepresented skin tones and rare diseases, impedes progress toward measurably fair methods. We introduce cgDDI (Controllable Generation of Diverse Dermatological Imagery), a hybrid framework that (1) synthesizes realistic ...
Background: Deep learning models can classify thyroid nodules on ultrasound, but reliable clinical decision support also requires calibrated probabilities, uncertainty estimation, and selective referral, particularly under dataset shift. Methods: We developed a calibrated deterministic five-member deep ensemble for ROI-based thyroid nodule classification and selective image-based triage. TN5000 ...
Primary tumor biopsy in retinoblastoma carries an unacceptable risk of extraocular dissemination. As a result, children treated with eye-sparing appro...
Accurate breast cancer risk prediction from screening mammography is critical for enabling personalized screening intervals and early detection. Recen...
Computed Tomography (CT) diagnosis often relies on dynamic selection of imaging phases, such as non-contrast, arterial, or venous phases, based on pre...
Glycosylation is a fundamental process regulating cellular function, tissue organization, and disease progression. However, comprehensive glycan profi...
Background: Nuclear medicine and radiopharmaceutical development require coordinated radiochemistry, dosimetry, molecular imaging, radiation-safety an...
Introduction: For oncology patients with limited treatment options, clinical trials may be a critical lifesaving pathway. Identifying relevant trials,...
Recurrent somatic mutations reveal cancer drivers, but in whole genomes many non-coding hotspots are passengers generated by localized mutational proc...
Many genomic assays begin with individual DNA fragments, but standard analysis quickly collapses those molecules into counts over genomic intervals. R...
Background: Multiple myeloma (MM) progression is accompanied by remodeling of the bone marrow immune microenvironment. Local interactions among malign...
Background. Diagnosis and risk stratification in rare hematologic malignancies such as myeloproliferative neoplasms (MPNs) - polycythemia vera (PV), e...
RNAGAN (version 2.0, https://github.com/ZhaozhengHou-HKU/RNAGAN-2.0.git) is a published foundation model that analyzes single-cell and bulk-level RNA ...
Molecular testing in hematology requires different assays for disease subgroup identification, risk stratification and selection of appropriate treatm...
Circulating tumor cells (CTCs) and immune cells form dynamic multicellular ecosystems in blood, but their spatial organization and clinical relevance ...
Cancer genomics and diagnostics is a rapidly evolving field in which identifying which topics attract early citation prominence can inform laboratory ...
Spatial transcriptomics (ST) has revolutionized our understanding of tumor biology but inherently lacks information on the upstream somatic driver mut...
Whole slide images (WSIs) provide rich diagnostic information for computational pathology, but their gigapixel scale, stain variation, scanner differe...
Predicting drug sensitivity across diverse cancer cell lines remains a fundamental challenge in precision oncology, particularly for data-scarce cell ...
AbstractThe infiltrative, non-enhancing margin of IDH wildtype high grade glioma (IDHwt HGG) harbors distinct molecular programs that drive invasion a...